Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Phenothiazine; D1/2 and α1-adrenergic antagoni...
ITC found in Nasturtium officinale (watercress)...
MGMT inhibitor.
Cholesterol ester transfer protein inhibitor.
Bactericidal
ATP-sensitive K+ channel activator, α-adrenerg...
BTK inhibitor.
Polyanionic sulfated glycosaminoglycan, endogen...
TRPC5 activator, NS4B and histamine H1 inhibito...
Peptide fragment of HIV-1 gp120.
Sulfonamide; folic acid synthesis inhibitor.
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Histamine H1 antagonist.
Protease inhibitor
Steroid lactone produced by Withania somnifera;...
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Non-nitrogen bisphosphonate; mitochondrial ATP/...
Fluoroquinolone; topoisomerase IV and bacterial...
Synthetic peptide, CDPK, PKC, CaMKII substrate....